Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
OPERATING ACTIVITIES    
Net income (loss) $ 111 $ (532)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Provision for doubtful accounts 47 6
Depreciation 5,801 5,395
Loss on disposal of and reserve adjustments for medical equipment 828 1,101
Gain on sale of medical equipment (1,402) (883)
Amortization of intangible assets 495 1,421
Amortization of deferred debt issuance costs 78 37
Stock-based compensation 1,736 2,170
Deferred income taxes (106) (435)
Changes in assets - (increase)/decrease:    
Accounts receivable (506) (924)
Inventories (885) (937)
Other current assets (994) 599
Other assets (1,719) (19)
Changes in liabilities - (decrease)/increase:    
Accounts payable and other liabilities (1,183) 2,496
NET CASH PROVIDED BY OPERATING ACTIVITIES 2,301 9,495
INVESTING ACTIVITIES    
Purchase of medical equipment (6,994) (6,669)
Purchase of property and equipment (494) (336)
Proceeds from sale of medical equipment, property and equipment 2,098 2,081
NET CASH USED IN INVESTING ACTIVITIES (5,390) (4,924)
FINANCING ACTIVITIES    
Principal payments on long-term debt (29,451) (20,665)
Cash proceeds from long-term debt 32,585 21,218
Debt issuance costs (229) 0
Cash payment of contingent consideration 0 (750)
Common stock repurchased as part of share repurchase program (153) (4,356)
Common stock repurchased to satisfy statutory withholding on employee stock-based compensation plans (523) (639)
Cash proceeds from stock plans 829 746
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 3,058 (4,446)
Net change in cash and cash equivalents (31) 125
Cash and cash equivalents, beginning of period 165 186
Cash and cash equivalents, end of period $ 134 $ 311